Compugen
CGEN
$2.17
Share price
-0.91%
Change (1 day)
110.68%
Change (1 year)
Categories
Operating Margin for Compugen (CGEN)
Operating Margin as of June 2024 (TTM): -89.54%
According to Compugen's latest financial reports and stock price the company's current Operating Margin is -89.54%. At the end of 2021 the company had an Operating Margin of -584.57%.
Operating Margin history for Compugen from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -584.57% | -62.88% |
| 2020 | -1,574.80% | |
| 2018 | -130.49% | |
| 2016 | -4,576.26% | 1929.54% |
| 2015 | -225.48% | 126.03% |
| 2014 | -99.76% | -79.23% |
| 2013 | -480.22% | -91.42% |
| 2012 | -5,595.87% | |
| 2010 | -706.55% | -76.85% |
| 2009 | -3,051.60% | -16.53% |
| 2008 | -3,655.92% | -47.19% |
| 2007 | -6,922.22% | 6.36% |
| 2006 | -6,508.37% | 182.59% |
| 2005 | -2,303.10% | 495.4% |
| 2004 | -386.81% | 140.15% |
| 2003 | -161.07% | 18.81% |
| 2002 | -135.57% | -19.03% |
| 2001 | -167.42% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Seagen
SGEN | -30.69% | -65.72% | 🇺🇸 USA |
 Genetic Technologies GENE | -105.42% | 17.74% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | -20.53% | -77.07% | 🇮🇱 Israel |
 Eterna Therapeutics ERNA | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.